Explore more topics
SEC Form 4 research

Xtant Medical Holdings, Inc. insider transactions

Inspect Xtant Medical Holdings, Inc.'s public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-14T07:26:40.310Z

Issuer CIK
0001453593
Reporting owners
52
Officers and directors
17
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Read one actual disclosure before using it

Show the table · 1 row, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

2026-08-192026-08-15JAIN ABHINAVA215,517$0Not reported

First displayed source row from Recent insider disclosures. The full bounded history and coverage notes remain below.

The displayed observation date is 2026-08-15 and its public availability date is 2026-08-19. Subtracting those calendar dates gives 4 days of disclosure lag. Historical public research can use the record from the availability date, rather than backdating knowledge to the observation date. The calendar-day difference does not assert an intraday publication time.

This row is code A: a award. An award is an acquisition but is not an open-market purchase. A purchase-following rule must not count it as code P.

Open the linked original receipts to verify the row, then inspect a second record before drawing a pattern. This public filing observation supplies source evidence, not a completed copy-trading return.

SEC accession 0001981291-26-000003 ↗SEC accession 0001975134-26-000001 ↗SEC accession 0001960742-26-000002 ↗

Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Show the table · 8 rows, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

2026-08-192026-08-15JAIN ABHINAVA215,517$0Not reported
2026-08-192026-08-15Beeson Jonn R.A215,517$0Not reported
2026-08-192026-08-15Schallenberger Mark A.A450,000$0Not reported
2026-08-192026-08-15Neils Scott CA400,000$0Not reported
2026-08-192026-08-15Browne Sean EA550,000$0Not reported
2026-08-192026-08-15Vizirgianakis Stavros G.A323,275$0Not reported
2026-08-192026-08-15Lipschultz TylerA215,517$0Not reported
2026-08-192026-08-15BAKEWELL JOHN KA215,517$0Not reported

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Inspect all 19 displayed rows: Officers and directors in the directory

Scroll sideways to compare all columns. Select a heading to sort.

Goldberger Daniel S000138204238
GANDOLFO JOHN P00012001558
Vizirgianakis Stavros G.00015598344
Brandt Kevin D00016926614
Browne Sean E00017904612
COOK GUY S000150846955
DEEDRICK JOHN ARTHUR00015579111
Eggenberg Michael00017325212
Godfrey Mitchell T00012983775
HOLMES DARREL LEE00015082054
JUDA GREGORY ALEXANDER00015467792
Kirschman David Louis00016490664
LOPACH MICHAEL A00015081423
Neils Scott C00019026103
ORBIMED ADVISORS LLC00010559511,020
Orbimed ROF II LLC00017679366
Rizzo Matthew00017325112
Swanson Kent L000129890613
WICKWIRE JON M.00015145465
Goldberger Daniel S ↗GANDOLFO JOHN P ↗Vizirgianakis Stavros G. ↗Brandt Kevin D ↗Browne Sean E ↗COOK GUY S ↗DEEDRICK JOHN ARTHUR ↗Eggenberg Michael ↗Godfrey Mitchell T ↗HOLMES DARREL LEE ↗JUDA GREGORY ALEXANDER ↗Kirschman David Louis ↗LOPACH MICHAEL A ↗Neils Scott C ↗ORBIMED ADVISORS LLC ↗Orbimed ROF II LLC ↗Rizzo Matthew ↗Swanson Kent L ↗WICKWIRE JON M. ↗

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.